Lexaria Bioscience (LEXX) Consolidated Net Income (2017 - 2026)
Lexaria Bioscience's Consolidated Net Income came in at -$1.99 million for fiscal Q3 2026 (quarter ended May 31, 2026), compared with -$3.79 million a year earlier.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Consolidated Net Income (2017 - 2026) Analysis & Trends
Over the trailing twelve months to May 31, 2026, Lexaria Bioscience reported Consolidated Net Income of -$7.74 million; for FY2025 (ended Aug 31, 2025), it came in at -$11.91 million.
- Going back by fiscal year, Consolidated Net Income was -$5.81 million in FY2024, -$6.71 million in FY2023, -$7.38 million in FY2022 and -$420,000 in FY2021.
- The five-year range for quarterly Consolidated Net Income is -$3.79 million (fiscal Q3 2025) to $2.01 million (fiscal Q1 2022).
- Business Quant data shows LEXX's Consolidated Net Income at -$1.45 million (Q2 2026), -$1.6 million (Q1 2026) and -$2.7 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Lexaria Bioscience | 3.04 Mn | -12.61 Mn | - | -1.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -1.99 Mn |
| Feb 28, 2026 | -1.45 Mn |
| Nov 30, 2025 | -1.60 Mn |
| Aug 31, 2025 | -2.70 Mn |
| May 31, 2025 | -3.79 Mn |
| Feb 28, 2025 | -2.72 Mn |
| Nov 30, 2024 | -2.71 Mn |
| Aug 31, 2024 | -2.19 Mn |
| May 31, 2024 | -1.78 Mn |
| Feb 29, 2024 | -652,733.00 |
| Nov 30, 2023 | -5,715.00 |
| Aug 31, 2023 | -1.25 Mn |
| May 31, 2023 | -2.38 Mn |
| Feb 28, 2023 | -1.31 Mn |
| Nov 30, 2022 | -1.77 Mn |
| Aug 31, 2022 | -1.51 Mn |
| May 31, 2022 | -2.42 Mn |
| Feb 28, 2022 | -1.45 Mn |
| Nov 30, 2021 | 2.01 Mn |
| Aug 31, 2021 | -2.87 Mn |
API Access
Lexaria Bioscience Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();